Managing cognitive impairment in patients with chronic obstructive pulmonary disease (COPD) in Saudi Arabia: what are the current practices?

Objective Cognitive impairment is a common comorbidity, yet overlooked, in patients with chronic obstructive pulmonary disease (COPD). However, little is known about the current practice and perceptions of physicians on recognising and managing cognitive impairment in patients with COPD in Saudi Ara...

Full description

Saved in:
Bibliographic Details
Main Authors: Rayan A. Siraj, Ahmed M. Alrajeh, Mushabbab A. Alahmari, Fahad H. Alahmadi, Abdulelah M. Aldhahir, Abdullah A. Alqarni, Jaber S. Alqahtani, Saeed M. Alghamdi, Turki M. Alanazi, Abdullah Alruwaili, Saleh S. Algarni, Abdulrhman S. Alghamdi, Tawah H. Alsindi, Mohammed M. Alyami, Faisal A. Alshehri, Talal Alshammari, Rehab Alhasani, Khalid Alrashed, Nawaf E. Sabir, Ataa F. Mesbah
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2024.2413924
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Cognitive impairment is a common comorbidity, yet overlooked, in patients with chronic obstructive pulmonary disease (COPD). However, little is known about the current practice and perceptions of physicians on recognising and managing cognitive impairment in patients with COPD in Saudi Arabia. This study aimed to investigate current practices and perceptions of physicians in Saudi Arabia regarding the recognition and management of cognitive impairment in COPD patients.Methods An online cross-sectional questionnaire was distributed between March and October 2023 to physicians in Saudi Arabia. The collected responses were analysed using descriptive statistics.Results A total of 808 physicians completed the online survey. Of whom, only 19% indicated receiving adequate training for managing cognitive impairment. Although the vast majority of physicians reported that cognitive impairment leads to underestimation of COPD severity (85%) and interferes with self-management (85%), only 11% agreed on the important role of screening. In addition, only half of the study participants aimed to identify possible cognitive impairment, with only 4% screening for cognitive impairment during patients’ assessment. The overall confidence level in recognising and managing cognitive impairment was relatively low. The most common barriers contributing to the suboptimal management of cognitive impairment in COPD were poor training (62%), the absence of standardised procedures (63%) and limited knowledge (58%) about cognitive impairment in COPD.Conclusion The current practice of recognising and managing cognitive impairment in Saudi Arabia is suboptimal. This is likely to be attributed to inadequate training, the absence of standardised procedures, and limited knowledge about cognitive impairment in COPD. Healthcare systems should provide more training and implement a holistic approach to detect and manage cognitive impairment during patients’ visits.
ISSN:0785-3890
1365-2060